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Elizabethkingia meningoseptica is a nosocomial non-fermenting gram-negative bacillus that has an increasing prevalence
in health care settings, especially in intensive care environments. While it has long been recognized as a rare but serious
cause of neonatal meningitis and sepsis, its role as a cause of ocular pathology is not well-known. We report the first case
of E. meningoseptica endogenous endophthalmitis caused by bacteraemia by the same organism. In view of its
aggressiveness and virulence in the eye, and the high rate of misdiagnosis or missed diagnosis of endogenous
endophthalmitis especially given its low incidence, we may wish to consider screening all cases of E. menigoseptica
bloodstream infections for endophthalmitis in future, similar to how it has become routine to refer all patients with
Klebsiella bacteraemia to ophthalmologists for screening for endophthalmitis in our local hospitals.
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Elizabethkingia meningoseptica (previously known as
Flavobacterium meningosepticum and then Chryseobacterium
meningosepticum) is a nosocomial non-fermenting gram-
negative bacillus that has intrinsic resistance to many anti-
biotics commonly used in intensive care settings [1,2]. In
addition, it carries many antimicrobial resistance genes, as
well as the ability to form biofilms and survive for long pe-
riods in a moist environment or in water sources includ-
ing tap water, making it an important organism in many
intensive care environments [3-5]. Unsurprisingly, out-
breaks of this bacteria have been reported, including a
recent publication reporting an outbreak in our local
hospital’s cardiothoracic and surgical intensive care units
(ICUs) in 2012 (Table 1) [6-10].
Endogenous bacterial endophthalmitis is a rare but
serious condition that occurs when bacteria cross the
blood–ocular barrier and multiply within the eye. While
E. meningoseptica has long been recognized as a rare but
serious cause of neonatal meningitis and sepsis, as well as
an increasingly important pathogen in healthcare environ-
ments, its role as a cause of ocular pathology is not well-
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both of which were post-traumatic and hence, ex-
ogenous, in nature [12,13]. We report the first case of
E. meningoseptica endogenous endophthalmitis caused
by bacteraemia by the same organism.Case presentation
A 75-year-old Chinese Singaporean lady with multiple
comorbidities including Type 2 diabetes mellitus on
insulin, hypertension, dyslipidemia, ischaemic heart dis-
ease, end-stage renal failure on hemodialysis, degenerative
spondylosis and osteoarthritis, was admitted for fever,
chills and rigors of one-day duration. There was also dis-
charge of pus over her right femoral dialysis catheter.
She was diagnosed to have disseminated Methicillin-
sensitive Staphylococcus aureus (MSSA) bacteraemia sec-
ondary to infected right femoral non-tunnelled dialysis
catheter. Her first nine blood cultures grew MSSA, so did
her wound culture. Her femoral line was removed and she
was treated in medical intensive care unit (MICU) for her
septic shock. She was referred to the infectious diseases
(ID) team and she received systemic vancomycin, clinda-
mycin and then cloxacillin over the course of several
weeks as culture results became known. The patient sub-
sequently improved clinically with resolution of fever and
improvement of haemodynamic parameters. Her inflam-
matory markers including procalcitonin and white bloodLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Table 1 Summary of outbreaks of Elizabethkingia meningoseptica
Period of
outbreak





4 neonates Not found Controlled by reinforcement of usual
measures
No additional colonization/infection








Hand cultures obtained from a senior
resident; Environmental cultures obtained
from powdered infant formula, an electrical
button, a computer keyboard, phone, a
doorknob, and an Ambu bag
Staff exchange in wards restricted; All
units thoroughly scrubbed using 2
disinfectants 3 times a day until outbreak
controlled; Contact precautions.
Nine patients improved on antimicrobial











Environmental sampling: one swab out of
106 surfaces; Patient sampling: E. meningoseptica
isolated from blood, respiratory specimen,
catheter tip
Training on handwashing and disinfection
practices, isolation policies, use of gowns
and gloves, policies implemented
regarding proper disposal of body fluids
Eight out of 19 died
Fall, 2006 [9] Orthopaedic wards 2 patients who had
allograft-associated
surgical site infections
E. meningoseptica was recovered from sink
drains and traps in clean rooms where
tissues were processed
All clean-room sink drains and traps at
processing facility replaced, check valves
in drains installed, routine sanitization of
drains started,
Tissue-processing resumed following
these changes; sterility failure rates
returned to baseline levels with no
identification of E. meningoseptica







5 patients E. meningoseptica was isolated from from
aerators, hand hygiene sinks
Urgent education programme instituted;
Taps were cleaned systematically and
aerators were changed.
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weeks after admission, there was documented clearance of
MSSA from her blood. The plan by ID was to continue
intravenous cloxacillin for a total of six weeks from her
last negative blood culture for the presumed endovascular
infection although she had a normal two dimensional
echocardiograph.
Unfortunately her stay in hospital was delayed as she
developed extensive right lower limb deep vein throm-
bosis, for which she was treated with heparin infusion,
inferior vena cava (IVC) filter and subsequently warfarin.
Approximately two months into her stay in hospital, she
developed an episode of sepsis with desaturation, drop
in Glasgow coma scale (GCS) and low grade fever. Ur-
gent neuroimaging revealed no intracranial infarct or
hemorrhage. However her subsequent four blood cul-
tures, taken two days apart, all grew Elizabethkingia
meningoseptica, which was susceptible to cotrimoxazole,
levofloxacin, and minocycline, but resistant to amikacin.
She was treated with intravenous antibiotics, comprising
courses of cotrimoxazole, cefazolin and meropenem, after
consultation with the ID team. Three days after her first
positive blood culture for Elizabethkingia meningoseptica,
she developed a red and painful left eye with blurring of
vision.
A referral to Ophthalmology was promptly made. On
examination her right pupil was noted to be sluggish,
and left pupil fixed. There was a reverse relative afferent
pupillary defect (RAPD). Visual acuity in her right eye
was 6/120 (without reading glasses) with no perception
of light (NPL) in her left eye. Examination of her left eye
showed an injected conjunctiva, hazy cornea with Desce-
met’s membrane (DM) folds, and a deep anterior cham-
ber filled with a hypopyon and fibrin. A glint of an
intraocular lens could be seen. There was no view of the
fundus but B-scan ultrasonography showed multiple vit-
reous opacities. The impression was that of left eye en-
dogenous endophthalmitis, for which she underwent an
intravitreal tap for vitreous culture, as well as injection
of intravitreal vancomycin and amikacin. She was also
started on hourly fortified gentamicin and cefazolin eye-
drops. In view of the absence of perception of light, as
well as her systemic status, vitrectomy was not resorted to.
There was also no immediate indication for evisceration.
The patient’s vitreous cultures came back positive for
Elizabethkingia meningoseptica, which was sensitive to
ciprofloxacin, levofloxacin, cotrimoxazole, and minocy-
cline, but resistant to ceftazidine, gentamicin and amikacin.
In consideration of the sensitivity results, the intravitreal
antibiotics were switched to ciprofloxacin (100 micro-
grams/0.05 ml). The injection was repeated five times be-
fore it was felt that the infection was under reasonable
control. The fibrin clot in her anterior chamber progres-
sively resolved and the inflammatory material in the vitreouscavity became organised. The eye was quiet with no pain.
While vision was not expected to recover, the need for evis-
ceration was successfully averted.
Potential environmental source links were investigated.
Workflows for ward staff were reviewed. Environmental
screening was performed by swab cultures of surfaces
and equipment within patient rooms, taps and aerators,
water sampling and sampling of chlorhexidine solution.
While no clear source of the bacteria was identified, it
was presumably from aerators and hand hygiene sinks,
as was found in a previous investigation of the same bac-
teria in the hospital [10].
Discussion
Elizabethkingia menigoseptica has reduced susceptibility
to a broad range of antimicrobials, including beta lac-
tams, aminoglycosides and chloramphenicol. It is an op-
portunistic pathogen being most often associated with
meningitis and septicemia in a pediatric (especially neo-
natal) population. It has also been identified as a cause
of healthcare-associated pneumonia, sepsis and meningi-
tis in adults, particularly in immunocompromised pa-
tients, those with indwelling central venous catheters
and those with long hospital stays. Mortality in pa-
tients with E. meningoseptica bacteraemia or meningi-
tis may be high (>50%) depending on the population
studied [7,14,15].
To date, there have only been two case reports on
E. meningoseptica-related endophthalmitis, both ex-
ogenous in nature, in contrast to our patient who had
an endogenous cause [12,13]. One was a case of delib-
erate ocular penetration with an unsterile sewing needle
in a patient with depressive illness, while the other was a
case of penetrating eye injury caused by a truck tyre explo-
sion resulting in a self-sealing full thickness corneal
wound with two metallic posterior segment foreign bodies
[13]. While the above two cases differ from ours in the na-
ture of the infection, there are similarities in all cases: the
infection in the eye occurred acutely, progressed very
quickly from one to three days, behaved virulently and
produced an intense fibrinous reaction in the anterior and
posterior segments of the eye. E. meningoseptica cultured
from the vitreous, like those from other parts of the body,
was found to be resistant to many antibiotics. Ciprofloxa-
cin was one antibiotic to which it was sensitive to in all
three cases, and hence may be considered as first-line
therapy (systemic and intravitreal) in future cases of
E. meningoseptica related endophthalmitis.
There have been no previous reports of E. meningoseptica
causing endogenous endophthalmitis, which occurs when
organisms reach the eye via the bloodstream, and enter the
internal ocular spaces by crossing the blood–ocular barrier.
Endogenous bacterial endophthalmitis is treated ser-
iously because they are serious infections with poor
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eral factors: delay in diagnosis, use of inappropriate an-
tibiotics, diffuse infection of the vitreous and retina or
panophthalmitis, poor vision at presentation, infection
with virulent organisms and gram negative infection [16].
Gram negative endophthalmitis is more common in East
Asian hospitals, with the most common bacteria being
Klebsiella spp, Escherichia coli, Pseudomonas aeruginosa,
Neisseria meningitides and Serratia marscescens. In fact
because of its virulence and prevalence, it has become
routine, in our local hospitals, to refer all patients with
Klebsiella bacteraemia to ophthalmologists for screening
for endophthalmitis.
Elizabethkingia menigoseptica, like Klebsiella spp, has
shown to behave in a virulent manner in the eye. With
its increasing prevalence in health care settings, espe-
cially in intensive care environments due to its propen-
sity to form biofilms, it is of utmost importance for
physicians to have a high vigilance for this opportunistic
pathogen. While its presence in the blood may not ne-
cessarily require an automatic referral for eye screening,
they should consider an early eye referral if the patient
has any signs (conjunctival injection or chemosis, periocu-
lar redness and swelling, hazy cornea, hypopyon in anter-
ior chamber, reduced or absent red reflex) or symptoms
(floaters, blurring of vision, eye pain, tearing, redness) of
an eye infection. However, in view of the aggressiveness
and virulence of this bacteria, and the likelihood of mis-
diagnosis or missed diagnosis of endogenous endophthal-
mitis especially given its low incidence, we may want to
consider screening all cases of E. menigoseptica blood-
stream infections for endophthalmitis in future.
This case also brings up the issue of potential contam-
ination of taps and aerators within ICUs as important
sources of E. meningoseptica infection as may have been
in this case [6,8,10]. E. meningoseptica is an opportunis-
tic pathogen that is well adapted to the intensive care
environment due to its intrinsic resistance to antimicro-
bials commonly used in the ICU setting and its propen-
sity to form biofilms. The latter are difficult to eradicate,
particularly where the organism has established on an
indwelling device such as a vascular line or endotracheal
tube.
Previous outbreaks have shown a multitude of poten-
tial sources of the bacteria, including sink drains, taps,
aerators, catheters, blood and respiratory specimens, hand
cultures, infant formula, electrical buttons, a computer
keyboards, phone, doorknobs, Ambu bags etc. [6-10].
Beyond the potential contribution of E. meningoseptica
to the deterioration of the severely ill adult patient,
transmission of E. meningoseptica from environmental
reservoirs to neonates is a known infection outbreak
scenario. Infection control personnel in acute care hospi-
tals must be aware of E. meningoseptica in chronically illpatients, especially those on mechanical ventilation in
ICUs. Attention should also be paid to non-adherence to
existing policies regarding disposal of patient secretions
and cleaning of re-usable patient care items, time pres-
sures and distance between patient rooms and ward utility
rooms notwithstanding.
Design of wards particularly within the critical care
setting must consider physical and personnel require-
ments to facilitate safe delivery of care, and staff work-
flows must be optimized to facilitate patient safety and
avoid inadvertently putting patients at risk with lapses in
safety procedures [10].
Conclusion
In conclusion, the incidence of endogenous endophthal-
mitis by E. meningoseptica and other bacteria is report-
edly low, but clinicians must not fail to appreciate the
overlap between ocular and systemic disease. Prompt
diagnosis and treatment is essential if useful vision is to
be preserved and therefore ophthalmologists, physicians,
and microbiologists need to have a high level of aware-
ness of this disease to reduce harm to our patients.
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